Covid-19 Archives

News and Trends 19 Jul 2022

SINOVAC starts influenza vaccine trial in Chile

Sinovac Biotech Ltd., a provider of biopharmaceutical products in China, has initiated a phase III clinical trial for SINOVAC’s inactivated quadrivalent influenza vaccine in Chile through a collaboration with the Pontificia Universidad Católica de Chile. SINOVAC said the results aim to provide scientific evidence to support its influenza vaccine immunogenicity and protection capacity. This clinical […]

July 19, 2022 - 2 minutesmins - By Jim Cornall

News and Trends 19 Jul 2022

SK Bioscience signs deal with Novavax to manufacture COVID-19 vaccine

South Korean company SK Bioscience has extended its partnership with Novavax, Inc., a U.S. biotechnology company specializing in next-generation vaccines, for the manufacturing and supply of Novavax COVID-19 vaccine targeting Omicron variants in prefilled syringes. SK Bioscience and Novavax signed an agreement for the technology transfer of Novavax proprietary COVID-19 variant antigen materials and manufacturing […]

July 19, 2022 - 2 minutesmins - By Jim Cornall

News and Trends 15 Jul 2022

WHO and UNICEF sound the alarm as global vaccination coverage continues to decline

Amid worldwide disruptions caused by the COVID-19 pandemic, WHO and UNICEF report the largest continued backslide in childhood vaccinations in approximately three decades, with 25 million infants missing out on lifesaving vaccines in 2021 alone. It was hoped that the cohort of children that missed their vaccinations in 2020 would be caught up in 2021, […]

July 15, 2022 - 4 minutesmins - By Omnia Ibrahim

covid-19 vaccine emergency use authorization

News and Trends 14 Jul 2022

FDA authorizes the first protein-based COVID-19 vaccine in the US

Novavax, Inc. has been given emergency use authorization (EUA) by the U.S. Food and Drug Administration (FDA) for its adjuvanted, protein-based COVID-19 shot. Branded Nuvaxovid and Covovax outside the U.S., Novavax’s vaccine is already approved for use in several countries worldwide, including the EU, U.K., Canada, Australia, South Korea and India. During public health emergencies, […]

July 14, 2022 - 2 minutesmins - By Omnia Ibrahim

More News! 8 Jul 2022

Beyond Biotech podcast 4: CorePath, Rensselaer, Versameb

This week’s guests are: Helen Zha, assistant professor of chemical and biological engineering and a member of the Center for Biotechnology and Interdisciplinary Studies (CBIS) at Rensselaer Polytechnic Institute; Versameb CEO Klaas Zuideveld; and Aamir Ehsan, CEO and medical director of CorePath and Celina Villa, medical director of Biopharma Division. Versameb gives presentation during World […]

July 8, 2022

News and Trends 7 Jul 2022

Vaccizone chooses partner to fast-track development of COVID-19 vaccine

A vaccine development company has chosen a partner to fast-track the development of its SARS-CoV-2 product for European clinical trials. Vaccizone has chosen viral vector contract development and manufacturing company (CDMO) antigen delivery technology Exothera S.A to accelerate the vaccine. Vaccizone is the inventor of the ASC Technology, a first-in-class antigen delivery platform for generating […]

July 7, 2022 - 3 minutesmins - By Liza Laws

News and Trends 27 Jun 2022

Chinese biotech company gets go-ahead for mRNA COVID-19 omicron trial in the Philippines

Jiangsu Recbio Technology Co., Ltd. has received clinical trial approval for R520A, a mRNA COVID-19 vaccine, from the Food and Drug Administration of the Philippines. R520A is an mRNA COVID-19 vaccine specifically targeting the Omicron variant. It was developed by Wuhan Recogen Biotechnology Co., Ltd., a subsidiary of the company. R520A adopts a self-developed lyophilization […]

June 27, 2022 - 1 minutemin - By Jim Cornall

News and Trends 27 Jun 2022

Covid vaccine granted marketing authorization in Europe

Specialty vaccine company, Valneva, has been given marketing authorization in Europe for its inactivated whole-virus COVID-19 vaccine VLA2001. This is a turnaround from the company’s situation in May of this year when the stock price was knocked down by 20% when gaining traction in the EU was proving to be a struggle. Despite authorization from […]

June 27, 2022 - 3 minutesmins - By Liza Laws

covid-19 vaccine bottles, manufacture supply line, vaccine development

How a global network accelerated the development of a virus-like particle vaccine against Covid-19

Vaccines are among the most effective ways to improve and protect human health. Whereas vaccines in Europe and North America are regarded as part of the general medical plan, vaccine supply has always been a pressing issue in African countries. In the current Covid-19 pandemic, the ability to develop and manufacture vaccines in Africa instead […]

June 23, 2022 - 5 minutesmins - By Ute Boronowsky

News and Trends 22 Jun 2022

US Toddlers and children to receive Covid-19 vaccine after emergency approval granted

Emergency authorization was granted for the use of the Pfizer-BioNTech Covid-19 vaccines on children from six months old to under five years of age. The US Food and Drug Administration made the authorization on Friday (June 17). All children ages 6 months and up are now eligible to receive the COVID-19 vaccine, following the US […]

June 22, 2022 - 3 minutesmins - By Liza Laws

News and Trends 22 Jun 2022

Rensselaer researchers make face masks to fight viruses

Researchers at Rensselaer Polytechnic Institute in Troy, NY, have developed N95 surgical face masks that are not just barriers to bacteria and viruses, but can also destroy them. The team said the antiviral, antibacterial masks can be worn for longer, creating less waste as the masks do not need to be replaced as frequently. Helen […]

June 22, 2022 - 3 minutesmins - By Jim Cornall

News and Trends 21 Jun 2022

Therorna funding to accelerate circRNA-based platform

Therorna Inc., a Chinese biotech company specializing in the development of circular RNA (circRNA) technology-based new vaccines and therapies, including for COVID-19, has completed a $42 million series A financing round. The funding was co-led by MSA Capital, with participation from Sherpa Healthcare Partners, 3H Health Investment, and existing investors Quan Capital and Cenova Capital. […]

June 21, 2022 - 2 minutesmins - By Jim Cornall

Knowledge hub

Categories

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Approaches

Therapeutic areas

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Covid-19

SINOVAC starts influenza vaccine trial in Chile

SK Bioscience signs deal with Novavax to manufacture COVID-19 vaccine

WHO and UNICEF sound the alarm as global vaccination coverage continues to decline

FDA authorizes the first protein-based COVID-19 vaccine in the US

Beyond Biotech podcast 4: CorePath, Rensselaer, Versameb

Vaccizone chooses partner to fast-track development of COVID-19 vaccine

Chinese biotech company gets go-ahead for mRNA COVID-19 omicron trial in the Philippines

Covid vaccine granted marketing authorization in Europe

How a global network accelerated the development of a virus-like particle vaccine against Covid-19

US Toddlers and children to receive Covid-19 vaccine after emergency approval granted

Rensselaer researchers make face masks to fight viruses

Therorna funding to accelerate circRNA-based platform

Subscribe to our newsletter to get the latest biotech news!

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!